BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2012 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]

By | 2016-03-03T12:00:12+00:00 May 15th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x March 31, 2012

[FORM 10-Q (Mark One) x March 31, 2012 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]

By | 2016-03-03T12:01:45+00:00 May 15th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CNET [ChinaNet Onlines,] NT 10-Q: (Original Filing)

[PART II (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense; x (b) (c) PART III State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof,uld not be filed within the]

By | 2016-02-08T11:10:05+00:00 May 15th, 2012|Categories: Chinese Stocks, CNET, SEC Original|Tags: , , , , , |0 Comments
Read More

SFUN [SouFun] 6-K: (Original Filing)

[SouFun Announces Unaudited First Quarter 2012 Results Revenues up 43.4% year-over-year to US$58.5 million. Operating income up 131.3% year-over-year to US$13.7million and non-GAAP operating income up 89.0% year-over-year to US$15.0 million. Net income attributable to shareholders up 152.9% year-over-year to US$14.5 million, and non-GAAP net income attributable to shareholders up 83.3% year-over-year to US$14.2 million. SouFun Company BEIJING, China, May]

By | 2016-03-08T00:31:47+00:00 May 15th, 2012|Categories: Chinese Stocks, SEC Original, SFUN|Tags: , , , , , |0 Comments
Read More

RCON [Recon Technology] 10-Q: (Original Filing)

[] [I, Yin Shenping, certify that: (1) I have reviewed this Form 10-Q of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [I, , certify that: (1) I have reviewed this Form 10-Q of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with this Form 10-Q periodic report of (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Yin Shenping Yin Shenping] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with this Form 10-Q periodic report of (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Liu Jia Liu Jia Chief Financial Officer (Principal Financial Officer)]

By | 2016-03-13T07:00:15+00:00 May 15th, 2012|Categories: Chinese Stocks, RCON, SEC Original|Tags: , , , , , |0 Comments
Read More

CREG [CHINA RECYCLING ENERGY] 10-Q:

[] [10.1 No.: Bank of XI’AN South City Loan (2012) No. 7 Loan Contract for Working Capital Borrower: Xi’an TCH Energy Technology Co., Ltd Address: 86# Gaoxin Road, Gaoxin district, Xi’an Legal Representative: Ku Guohua Phone: Lender: Bank of XI’AN Co., Ltd. South City Branch Address: 1# Nan Guan Zheng Road Legal Representative: Li Peilin Phone: 87818014 Catalog Provision I Type] [CONVERTIBLE PROMISSORY NOTE TRANSFER AGREEMENT This CONVERTIBLE PROMISSORY NOTE TRANSFER AGREEMENT (the “Agreement”) is entered into as of the 28th day of April, 2012, by and among, Great Essential Investment, Ltd., a company registered in the Virgin Islands (“Great Essential”), Carlyle Asia Growth Partners III, L.P., a limited partnership organized under the laws of the Cayman Islands (“CAGP”) and CAGP] [CERTIFICATIONS I, Guohua Ku, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, David Chong, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. May 15, 2012 Guohua Ku Chairman of the Board and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. May 15, 2012 David Chong Chief Financial Officer and Secretary]

By | 2016-03-21T13:46:12+00:00 May 15th, 2012|Categories: Chinese Stocks, CREG, Webplus ver|Tags: , , , , , |0 Comments
Read More

CNET [ChinaNet Onlines,] NT 10-Q: PART II (a) The reasons described in reasonable

[PART II (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense; x (b) (c) PART III State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof,uld not be filed within the]

By | 2016-02-08T11:10:36+00:00 May 15th, 2012|Categories: Chinese Stocks, CNET, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar